Stratos Wealth Partners, LTD.
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1612865
BEACHWOOD, OH
Position in BCRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$147,000
+$7,056 QoQ
Shares Held
14,700
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#226
of 316 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Stratos Wealth Partners, LTD. holds $4,102,050 across 8 Drug Manufacturers - Specialty & Generic names. BCRX ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
35,783 | $2,571,366 | |
| 2 | VTRS |
Viatris Inc
|
27,535 | $437,255 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
3,170 | $351,679 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,340 | $248,679 | |
| 5 | HROW |
Harrow, Inc.
|
5,498 | $233,500 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
14,700 | $147,000 | |
| 7 | HLN |
Haleon plc
|
10,278 | $95,893 | |
| 8 | INM |
InMed Pharmaceuticals Inc.
|
10,760 | $16,678 |
All Filings in BCRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $147,000 | 14,700 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $139,944 | 14,700 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $114,660 | 14,700 | Shares | Sole | 2026-01-20 | |
| No filing history on record for this holder in this stock. | ||||||